Themis Medicare Limited Total Assets
Themis Medicare Limited total assets. Based on the latest financial reports, Themis Medicare Limited (THEMISMED) holds total assets worth Rs5.98 Billion INR (≈ $64.66 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Themis Medicare Limited market cap and net worth for the company's overall valuation and market capitalisation.
Total Assets of Themis Medicare Limited (2006–2026)
Total assets of Themis Medicare Limited from 2006 to 2026. This chart illustrates how Themis Medicare Limited's total assets have evolved over time, based on quarterly financial data. See THEMISMED share price today for real-time trading data and today's change.
Themis Medicare Limited - Asset Composition Analysis
Themis Medicare Limited Total Assets Breakdown (March 2026)
Themis Medicare Limited total assets breakdown as of March 2026. Themis Medicare Limited's total assets of Rs5.98 Billion consist of 51.0% current assets and 49.0% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 1.5% |
| Accounts Receivable | Rs1.78 Billion | 29.8% |
| Inventory | Rs810.87 Million | 13.6% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs1.15 Million | 0.0% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2006–2026)
This chart illustrates how Themis Medicare Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Themis Medicare Limited (THEMISMED) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Themis Medicare Limited's current assets represent 51.0% of total assets in 2026, a decrease from 55.4% in 2006.
- Cash Position: Cash and equivalents constituted 1.5% of total assets in 2026, down from 1.7% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 2006.
- Asset Diversification: The largest asset category is accounts receivable at 29.8% of total assets.
Themis Medicare Limited Competitors by Total Assets
Key competitors of Themis Medicare Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
|
China | CN¥9.54 Billion |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211
|
China | CN¥6.44 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Bide Pharmatech Co. Ltd. A
SHG:688073
|
China | CN¥2.54 Billion |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976
|
China | CN¥4.69 Billion |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365
|
China | CN¥2.26 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥25.73 Billion |
Themis Medicare Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.84 | 1.95 | 1.45 |
| Quick Ratio | 1.35 | 1.41 | 0.99 |
| Cash Ratio | 0.00 | 0.04 | 0.00 |
| Working Capital | Rs1.39 Billion | Rs1.48 Billion | Rs571.63 Million |
Themis Medicare Limited - Advanced Valuation Insights
This section examines the relationship between Themis Medicare Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.83 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | 1.7% |
| Total Assets | Rs5.98 Billion |
| Market Capitalization | $99.33 Million USD |
Valuation Analysis
Below Book Valuation: The market values Themis Medicare Limited's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Themis Medicare Limited's assets grew by 1.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Themis Medicare Limited (2006–2026)
The table below shows the annual total assets of Themis Medicare Limited from 2006 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs5.98 Billion ≈ $64.66 Million |
+1.68% |
| 2025-03-31 | Rs5.88 Billion ≈ $63.59 Million |
+3.82% |
| 2024-03-31 | Rs5.66 Billion ≈ $61.26 Million |
+10.21% |
| 2023-03-31 | Rs5.14 Billion ≈ $55.58 Million |
+20.14% |
| 2022-03-31 | Rs4.28 Billion ≈ $46.26 Million |
+15.26% |
| 2021-03-31 | Rs3.71 Billion ≈ $40.14 Million |
+6.07% |
| 2020-03-31 | Rs3.50 Billion ≈ $37.84 Million |
+11.40% |
| 2019-03-31 | Rs3.14 Billion ≈ $33.97 Million |
+2.90% |
| 2018-03-31 | Rs3.05 Billion ≈ $33.01 Million |
-1.45% |
| 2017-03-31 | Rs3.10 Billion ≈ $33.50 Million |
+12.18% |
| 2016-03-31 | Rs2.76 Billion ≈ $29.86 Million |
-1.13% |
| 2015-03-31 | Rs2.79 Billion ≈ $30.21 Million |
-1.97% |
| 2014-03-31 | Rs2.85 Billion ≈ $30.81 Million |
+4.21% |
| 2013-03-31 | Rs2.73 Billion ≈ $29.57 Million |
-2.21% |
| 2012-03-31 | Rs2.80 Billion ≈ $30.24 Million |
-4.90% |
| 2011-03-31 | Rs2.94 Billion ≈ $31.79 Million |
+6.49% |
| 2010-03-31 | Rs2.76 Billion ≈ $29.86 Million |
-6.22% |
| 2009-03-31 | Rs2.94 Billion ≈ $31.84 Million |
+7.93% |
| 2008-03-31 | Rs2.73 Billion ≈ $29.50 Million |
+17.87% |
| 2007-03-31 | Rs2.31 Billion ≈ $25.02 Million |
+47.01% |
| 2006-03-31 | Rs1.57 Billion ≈ $17.02 Million |
-- |
About Themis Medicare Limited
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It provides active pharmaceutical ingredients (APIs) and formulations used in various therapeutic areas, including analgesic and anti-inflammatory, analgesic and antispasmodic, analgesics, anesthesia, antacid-antiflatulent, anti-fungal, antibiotic, anti-diabetic, a… Read more